INTRODUCTION
============

Intermediate filaments, actin filaments, and microtubules are the main components of the metazoan cytoskeleton and are involved in most cellular processes. The contribution and properties of the three components differ, however. The least investigated elements are the molecularly highly diverse intermediate filaments. In contrast to actin filaments and microtubules, they are not essential for either cell division or basic cell functions. Yet mutations in intermediate filament genes have been implicated in more than 80 human diseases ([@B49]).

Intermediate filaments have unique mechanical properties. They are highly flexible and extensible but support, at the same time, cellular stiffness ([@B61]; [@B54]; [@B59]; [@B46]). Their contribution to mechanical stress resilience is reflected by the large number of blister-forming diseases that are caused by single-point mutations of epithelial keratin intermediate filament--encoding genes ([@B24]). Besides these mechanical functions, intermediate filaments are involved in the regulation of cell growth, apoptosis, and vesicle trafficking to name but a few other functions ([@B34]; [@B41]; [@B68]). To facilitate these functions, intermediate filaments form complex three-dimensional networks whose arrangement depends on the cell type, cell cycle stage, and functional state.

A particularly striking arrangement of the intermediate filament cytoskeleton is encountered in intestinal epithelial cells. The bulk of intermediate filaments is concentrated in a dense fibrous layer just below the apical terminal web of actin and spectrin in these cells. These layers are anchored to the apical junctional complex in vertebrates including fish ([@B42]), amphibians ([@B43]), and mammals ([@B27]). This remarkable distribution is also conserved in the nematode *Caenorhabditis elegans*, in which intermediate filaments localize to the prominent endotube ([@B3]; [@B6]; [@B81]). It has been also observed in the basal hexapod *Isotumurus maculatus*, which---in contrast to other hexapods---expresses cytoplasmic intermediate filaments ([@B45]). Taken together, these findings indicate it is likely that the highly conserved distribution pattern is advantageous to intestinal cells and suggests that it strengthens the mucosal barrier function ([@B82]).

The intermediate filament--rich subapical network might form an intracellular barrier to the cytoplasmic space beneath and is closely attached to the organelle-free terminal web above, which serves as an anchor for the actin bundles that protrude into the microvilli of the overlying brush border ([@B23]). The terminal web contains myosins, spectrins, actin, and an assortment of actin-binding proteins (see reviews in [@B48]; [@B14]; [@B37]; [@B67]). Assembly of the terminal web has been studied during gut development in vertebrates ([@B8]), but its relationship to the intermediate filament network is still largely unexplored.

To identify structural determinants and regulatory components of the intestinal cytoskeleton and to study its functional contribution to intestinal physiology, we performed a mutagenesis screen using a reporter strain producing cyan fluorescent protein (CFP)-tagged intermediate filament protein IFB-2::CFP exclusively in the intestinal endotube ([@B26]). Using this strategy, we recently identified the novel intestinal filament organizer IFO-1, which acts as a structural component to localize the intermediate filament--rich endotube to the periluminal subapical cytoplasmic region of intestinal cells ([@B5]). Here we characterize mutants of the MAP kinase 7 orthologue SMA-5, which has been linked to growth regulation ([@B73]), and show that *sma-5* alleles induce the development of bubble-shaped invaginations of the apical plasma membrane together with the associated actin and modified intermediate filament cytoskeleton into the cytoplasm of intestinal cells.

RESULTS
=======

SMA-5 mutations induce IFB-2::CFP--labeled cytoplasmic invaginations in the intestine
-------------------------------------------------------------------------------------

Allele *kc1* was selected in a mutagenesis screen of IFB-2::CFP--expressing strain BJ52 (details in [@B5]). Fluorescence microscopy of outcrossed homozygous strain BJ132 revealed that the circumferential localization of the IFB-2--labeled endotube was disrupted presenting multiple bubble-shaped IFB-2::CFP--positive protrusions into the apical cytoplasm along the entire length of the adluminal surface of all intestinal epithelial cells ([Figure 1, A and B](#F1){ref-type="fig"}). These alterations were not detectable during embryogenesis (unpublished data) and larval development ([Figure 1C](#F1){ref-type="fig"}) but emerged from early adulthood onward ([Figure 1D](#F1){ref-type="fig"}), increasing in number throughout the intestine during aging ([Figures 1B](#F1){ref-type="fig"} and [2, B, E, and H](#F2){ref-type="fig"}).

![Mutations in the *sma-5* gene induce bubble-shaped protrusions of IFB-2::CFP into the cytoplasm of intestinal cells. The fluorescence images (inverse presentation; composite images in B, E, and F) show IFB-2::CFP distribution. Note the smooth and even periluminal localization of IFB-2::CFP in the adult wild-type background (WT; strain BJ52; A), while multiple protrusions along the entire intestine are readily detectable in the adult *kc1* mutant (B). Note also that the *kc1* L1 larva in C is still devoid of invaginations and that the young adult in D presents some invaginations but not as many as the older adult in B. Enlargements correspond to boxed areas. (E, F) Similar multiple cytoplasmic invaginations of IFB-2 are also present in worms treated with *sma-5(RNAi)* and in mutants carrying a partial deletion of the *sma-5* gene (allele *n678*). Scale bars: 100 μm in A, B, D, E, F, and inset in D; 50 μm in inset of B; 10 μm in C and inset in C.](3855fig1){#F1}

![Development of the *sma-5* phenotype is age-dependent. IFB-2::CFP fluorescence (inverse presentation) was recorded 1 d (A--C), 2 d (D--F), and 4 d (G--I) after hatching. The percentage of animals showing a cytoplasmic invagination phenotype is shown at right. Wild-type animals were completely devoid of invaginations at all time points (A, D, G; 1 d: 0% \[*n* = 0/16\]; 2 d: 0% \[*n* = 0/13\]; 4 d: 0% \[*n* = 0/21\]), while a few *sma-5(kc1)* animals displayed scarce invaginations at 1 d (B; 9.10% \[*n* = 2/22\]). A substantial increase in number of affected animals and density of cytoplasmic invaginations occurred during aging (E, H; 2 d: 50.82% \[*n* = 31/61\]; 4 d: 87.04% \[*n* = 47/54\]). Most animals carrying allele *n678* presented cytoplasmic invaginations already 1 d after hatching (C; 94.12% \[*n* = 16/17\]) and 2 d after hatching (F; 2 d: 94.74% \[*n* = 18/19\]), leading to full penetrance by 4 d after hatching (I; 4 d: 100% \[*n* = 28/28\]). Scale bars: 20 μm in A--I; 10 μm in inset of F; 20 μm in all other insets.](3855fig2){#F2}

We used chromosomal and subchromosomal single-nucleotide polymorphism mapping to localize the *kc1* mutation to the interval between 6.6 and 6.97 cM on the X chromosome, a region encompassing 94 protein-coding genes. The *kc1*-like phenotype was then mapped by bacterial feeding and microinjection of dsRNA to the *sma-5* gene W06B3.2 ([Figure 1E](#F1){ref-type="fig"}), which had been recently characterized by [@B73]). They showed that its mutation (allele *n678*) causes small body size despite unaltered cell numbers, slow growth, and abnormal intestinal granules. Aberrations of the intestinal cytoskeleton, however, were not investigated in this study. We therefore crossed the *sma-5(n678)* allele into the *ifb-2::cfp* reporter background. The resulting worms presented an even more severe phenotype of IFB-2::CFP distribution than those carrying the *sma-5(kc1)* allele, with many more invaginations in adults and already detectable invaginations in early larval stages ([Figures 1F](#F1){ref-type="fig"} and [2, C, F, and I](#F2){ref-type="fig"}).

To demonstrate that a lack of functional SMA-5 is responsible for the *kc1* phenotype, we performed rescue experiments with a fosmid construct that we obtained from the TransgeneOme Project (<https://transgeneome.mpi-cbg.de/transgeneomics/index.html>). This construct encodes the SMA-5--enhanced green fluorescent protein (EGFP) fusion protein SMA-5::EGFP. Microinjection of fosmid DNA into the gonads of *sma-5(kc1)* and *sma-5(n678)* animals efficiently rescued the bubble-shaped invaginations observed in matched control animals ([Figure 3, A--B″](#F3){ref-type="fig"}). Similarly, intestine-specific expression of SMA-5 using the *vha-6* promoter ([@B84]) also rescued the phenotype ([Figure 3, C--D′](#F3){ref-type="fig"}). Furthermore, the SMA-5::EGFP fluorescence was exclusively detected in the cytoplasm of intestinal cells in strain BJ269 ([Figure 3, B′ and B″](#F3){ref-type="fig"}). This was somewhat in contrast to the previous observations of [@B73]), who found expression of two *sma-5* reporter constructs, which contain 1.6 kb of the upstream region and either almost none or all of the gene-coding region, not only in the intestine but also in the excretory cell and to some degree in the hypodermis. In addition, our observations were in disagreement with the distribution of another reporter containing 4.9 kb of the region upstream of exon 1 described by the same group, the expression of which was noted only in the pharynx and hypodermis. To exclude that the *kc1* background is responsible for the observed differences, we also injected fosmid DNA into strain DP38 *unc-119(ed3)* leading to progeny expressing the wild-type copy of *unc-119* together with the *sma-5::egfp* transgene. Fluorescence analyses of resulting non-*unc* strain BJ263 again showed intestine-restricted cytoplasmic expression of the fluorescent reporter with no detectable fluorescence in the pharynx, hypodermis, or excretory cell ([Figure 4](#F4){ref-type="fig"}). A localized dot-like signal was seen in the somatic gonad in situ and in dissected worms when using anti-GFP antibodies after long exposure times ([Figure 4, D′, E′, and F′](#F4){ref-type="fig"}). Of note, SMA-5::EGFP fluorescence intensity was highest at the apical pole of intestinal cells ([Figure 4B′](#F4){ref-type="fig"}). To further assess whether SMA-5 function for intermediate filament organization is restricted to the intestine, we investigated the effect of *sma-5(RNAi)* on IFA-1 distribution in the marginal cells of the pharynx and of IFB-1 distribution in the hypodermis. In contrast to IFB-2, these intermediate filaments remained properly arranged upon SMA-5 depletion (Supplemental Figure S1; compare with wild-type distribution in [@B32]; [@B75]).

![The *sma-5* phenotype can be fully rescued by *sma-5::egfp* and intestine-specific *vha-6p::sma-5* expression. (A--B″) The images show immunofluorescence micrographs of dissected adult intestines depicting the staining of anti--IFB-2 (A, B) and anti-GFP delineating the distribution of SMA-5::EGFP (A′, B′; merged images in A″ and B″) in *sma-5(kc1)* animals (A--A″) and in *sma-5(kc1)* animals producing a SMA-5::EGFP fusion protein (B--B″). Note the disappearance of the multiple cytoplasmic invaginations of the IFB-2 network in the rescued intestine. The pancytoplasmic localization of SMA-5::EGFP in the intestine can be appreciated in B′ and B″ (nuclei devoid of fluorescence marked by asterisks). The outline of the intestine is demarcated by broken lines in A′. (C--D′) Fluorescence micrographs (inverse presentation) of living worms depicting the distribution of IFB-2::CFP in *sma-5(n678)* animals (C) and in *sma-5* animals microinjected with the intestine-specific expression construct *vha-6p::sma-5* (strain BJ301; low and high magnification in D and D′, respectively). Note the efficient rescue of the intestinal cytoplasmic invagination phenotype in the microinjected worm. Scale bars: 20 μm.](3855fig3){#F3}

![SMA-5::EGFP is detected throughout the entire intestine and weakly in restricted regions of the somatic gonad. The in vivo fluorescence pictures in A′--D′ (corresponding interference contrast images in A--D) and immunofluorescence pictures of dissected intestines detecting GFP (E--F′) show expression of an extrachromosomal *sma-5::egfp*--containing fosmid. Note that the fluorescence is restricted to the cytoplasm of enterocytes, with prominent apical enrichment in some instances (arrowheads in B) with no detectable expression in either pharynx (P) or gonad (Go) even after overexposure (E′ and F′). Occasionally, localized expression was noted in the somatic gonad (asterisks in D′, E′, and F′) Scale bars: 50 μm in A--D′; 25 μm in E--F′.](3855fig4){#F4}

*sma-5(kc1)* carries a point mutation in the region encoding a highly conserved catalytic serine--threonine kinase domain
-------------------------------------------------------------------------------------------------------------------------

The WormBase gene model ([www.wormbase.org](http://www.wormbase.org)) of the *sma-5* gene predicts four protein isoforms: a, b, c, and d. They give rise to polypeptides with a molecular weight of 56.7 kDa (a), 55 kDa (b), 57.6 kDa (c), and 51.3 kDa (d) and isoelectric points of 7.4, 6.61, 6.71, or 6.94, respectively. Further analysis based on RNAseq data suggests the appearance of alternative splice variants of isoform c (c1 and c2) and isoform d (d1 and d2) (Supplemental Figure S2). Of note, the cDNA corresponding to isoform a was used to successfully rescue the intestinal phenotype using the *vha-6* promoter ([Figure 3, D and D′](#F3){ref-type="fig"}).

A BLAST (Basic Local Alignment Search Tool) search revealed that SMA-5 orthologues are present in other nematodes including *Caenorhabditis remanei*, *Caenorhabditis japonica*, *Caenorhabditis briggsae*, *Pristionchus pacificus*, and *Caenorhabditis brenneri* with amino acid similarities of 99.2, 98.2, 94.9, 78.2, and 77.4%, respectively. More importantly, searches in the KEGG database ([www.genome.jp/kegg](http://www.genome.jp/kegg)) showed that SMA-5 orthologues are conserved throughout the animal kingdom, including in the model organisms *Drosophila melanogaster* and *Danio rerio* (Supplemental Figure S3). The human SMA-5 orthologue still shows a similarity of 36% to the nematode counterpart. It encodes the 816 amino acid isoform 1 of mitogen-activated protein kinase 7 (BMK1/ERK5; ENSP00000311005).

Sequencing the entire *sma-5* gene of *kc1* animals showed that the gene contains a single point mutation (position 998 in CELE_W06B3.2a) resulting in a change of R~125~ (C**[G]{.ul}**C) into H~125~ (C**[A]{.ul}**C) (marked in yellow in Supplemental Figure S3). Protein domain analysis using the SMART-server (<http://smart.embl-heidelberg.de>) identified SMA-5 as a serine--threonine kinase with a typical catalytic domain located between amino acids 81 and 388 in isoform a. Remarkably, R~125~ is contained in a highly conserved sequence motif, which shows similarities to *D. melanogaster* (38.5%), *D. rerio* (40.4%), and *Homo sapiens* (42.3%). R~125~ is just three amino acids away from one of the essential and also fully conserved amino acids (E~129~; marked in blue in Supplemental Figure S3). This can be taken as an indication for dysfunctional kinase activity of the *kc1*-encoded SMA-5 mutant protein. In contrast, the *sma-5(n678)* allele contains a 226 base pair deletion of the 3′ coding region of *sma-5*, leading to truncation of the last 75 amino acids in addition to a complete ∼15 kb deletion of the downstream genes C49F5.3, C49F5.5, C49F5.6, and C49F5.7 ([@B73]).

*sma-5* mutants are small and have reduced brood size, slower larval development, and decreased life span
---------------------------------------------------------------------------------------------------------

Next we wanted to investigate the consequences of the altered intestine for worm growth, replication, development, and survival. The histogram in [Figure 5A](#F5){ref-type="fig"} shows that *sma-5(kc1)* worms were smaller (1.11 ± 0.05 mm; *n* = 38) than the wild type (1.27 ± 0.06 mm; *n* = 54; *p* \< 0.001) and that *sma-5(n678)* worms were even smaller (0.72 ± 0.10 mm; *n* = 37; *p* \< 0.001). Furthermore, the number of progeny was significantly (*p* \< 0.001) less in *sma-5(kc1)* (168 ± 29; *n* = 40) and *sma-5(n678)* (69 ± 22; *n* = 44) than in the wild type (209 ± 21; *n* = 50; [Figure 5B](#F5){ref-type="fig"}). Increased embryonic lethality was not observed in the mutants (unpublished data), but development was considerably (*p* \< 0.001) prolonged in the mutants ([Figure 5C](#F5){ref-type="fig"}). Time of development at 18°C was 5.01 ± 0.11 d in the wild type (*n* = 265), 5.59 ± 0.49 d in *sma-5(kc1)* (*n* = 269), and 7.36 ± 0.65 d in *sma-5(n678)* (*n* = 181). In addition, a reduced life span was observed in both *sma-5* alleles (*kc1*: 19 d; *n* = 468; *n678*: 17 d; *n* = 461) versus the wild type (25 d; *n* = 512; *p* \< 0.001) ([Figure 5D](#F5){ref-type="fig"}).

![*sma-5* mutations lead to impaired growth, reduced brood size, slowed development, and decreased survival. (A) The histogram shows that *sma-5(kc1)* and *sma-5(n678)* worms are smaller (1.11 ± 0.05 mm \[*n* = 38\] and 0.72 ± 0.10 mm \[*n* = 37\], respectively) than the wild type (1.27 ± 0.06 mm; *n* = 54; *p* \< 0.001). (B) The number of progeny is significantly (*p* \< 0.001) smaller in *sma-5(kc1)* (168 ± 29; *n* = 40) and *sma-5(n678)* (69 ± 22; *n* = 44) than in the wild type (209 ± 21; *n* = 50). (C) The time of development at 18°C is considerably (*p* \< 0.001) prolonged in *sma-5(kc1)* (5.59 ± 0.49 d; *n* = 269) and *sma-5(n678)* (7.36 ± 0.65 d; *n* = 181) compared with the wild type (5.01 ± 0.11 d; *n* = 265). (D) Life span is considerably reduced in both *sma-5* alleles (*kc1*: 19 d \[*n* = 468\]; *n678*: 17 d \[*n* = 461\]) vs. the wild type (25 d; *n* = 512; *p* \< 0.001).](3855fig5){#F5}

To demonstrate that the phenotype was caused by intestine-specific loss of SMA-5 function, we performed *sma-5(RNAi)* experiments in strain OLB11, which facilitates selective RNA interference (RNAi) in the intestine ([@B53]). These animals not only replicated the characteristic cytoplasmic invaginations in the intestine but also showed reduced growth, retarded development, and reduced brood size (Supplemental Figure S4). Conversely, SMA-5::EGFP expression in *n678* mutants not only rescued the intestinal phenotype but also rescued body size (935.0 ± 10.42 μm; *n* = 46 in rescued worms vs. 1035 ± 14.63 μm; *n* = 41 in wild type and 603.4 ± 15.99 μm; *n* = 47 in *n678* mutants; *p* \< 0.0001). Taken together, the observed phenotypes are indicative of compromised food resorption.

*sma-5* mutations induce an overall reorganization of the apical cytoskeleton in the intestine but do not perturb junction localization and integrity
-----------------------------------------------------------------------------------------------------------------------------------------------------

Differential interference contrast microscopy revealed that the bubble-shaped structures bulged out from the intestinal lumen (arrows in [Figure 6, B--D](#F6){ref-type="fig"}). These invaginations were much more frequent and pronounced in *n678* than in *kc1* mutants. The adjacent apical domain, however, was still inconspicuous (arrowheads in [Figure 6, B--D](#F6){ref-type="fig"}). Luminal width was often enlarged, especially in *n678* mutants (asterisks in [Figure 6D](#F6){ref-type="fig"}). To find out whether these invaginations are connected to the intestinal lumen and whether they are surrounded by IFB-2, we performed feeding experiments with the membrane-impermeable dye Texas Red-dextran in IFB-2::CFP reporter strains (*n* = 50). The dye was restricted to the intestinal lumen in wild-type and mutant worms, demonstrating that the intestinal barrier remains intact. In addition, the dye filled all the luminal pockets that herniate into the cytoplasm in the *kc1* (*n* = 50) and *n678* mutants (*n* = 50; [Figure 6, E--G″](#F6){ref-type="fig"}). These cytoplasmic invaginations were surrounded by IFB-2::CFP fluorescence, which often appeared to be discontinuous.

![*sma-5* mutations induce cytoplasmic IFB-2--positive invaginations connected to the intestinal lumen that is often dilated. (A--D) The differential interference contrast microscopic images depict the characteristic even-shaped lumen (arrowheads) in wild-type N2 (WT; A), while multiple cytoplasmic invaginations (arrows) and local luminal expansions (asterisks) occur in *sma-5(kc1)* and *sma-5(n678)* mutants next to normal-appearing sections (arrowheads; B--D). (E--G″) Fluorescence micrographs detect IFB-2::CFP and Texas Red--labeled dextran after feeding in wild-type (E--E″; *n* = 50), *sma-5(kc1)* (F--F″; *n* = 50), and *sma-5(n678)* (G--G″; *n* = 50) intestines. Note that the membrane-impermeable dye is restricted to the even-shaped lumen in the wild type but enters bubble-shaped protrusions that are surrounded by cytoplasmic IFB-2::CFP in both mutants. The intestinal barrier remains intact in the mutants. Scale bars: 20 μm in A--D; 10 μm in E--G″.](3855fig6){#F6}

To examine the structural and topological integrity of the *C. elegans* apical junction (CeAJ), we performed immunofluorescence microscopy on isolated adult intestines with antibodies directed against the junctional MAGUK protein DLG-1 ([Figure 7, A″--C″](#F7){ref-type="fig"}). The localization and continuity of immunostaining was unperturbed in the mutants presenting the characteristic ladder pattern. This result further supports the dextran-feeding experiments demonstrating that the intestinal barrier function is still fully intact. Next we wanted to study the effect of *sma-5* mutation on other intermediate filament polypeptides in the intestine. [Figure 7, A--C′](#F7){ref-type="fig"}, shows that IFC-2 perfectly colocalizes with IFB-2 in both the wild-type and mutant intestines. To test, whether and how other components of the apical cytoskeleton are affected, we studied the distribution of F-actin. As expected, phalloidin staining showed apical F-actin enrichment next to IFB-2 immunoreactivity (e.g., [@B5]). This codistribution was maintained in the mutants with F-actin staining in the IFB-2--positive cytoplasmic invaginations ([Figure 7, D--F″](#F7){ref-type="fig"}). In the following set of experiments, we looked at the cytoskeletal linker ezrin--radixin--moesin *C. elegans* orthologue ERM-1, which links actin to the plasma membrane ([@B20]; [@B70]; [@B16]; [@B15]). As exemplified in [Figure 7, H--I″](#F7){ref-type="fig"}, ERM-1 also localizes to the cytoplasmic invaginations of both *sma-5* mutants. Taking these findings together, we conclude that the entire apical membrane domain is displaced into the cytoplasm of *sma-5* mutants, and these invaginations remain in direct contact with the intestinal lumen.

![The subapical membrane domain invaginates coordinately into the apical cytoplasm of intestinal cells without affecting junction localization in *kc1* and *n678* mutants. The micrographs depict results of fluorescence microscopic detection of apical components in dissected intestines. (A--C″) Triple immunofluorescence detecting the endotube components IFB-2 (left) and IFC-2 (middle) together with the CeAJ component DLG-1 (right) in N2 (WT) and *sma-5* mutants (*sma-5(kc1)*, *sma-5(n678)*). (D--F″) Double fluorescence microscopy localizing IFB-2 with antibodies (left) and F-actin with Alexa Fluor 546--conjugated phalloidin (middle; superimposed images at right) in wild-type and *sma-5* mutant intestines. (G--I″) Double immunofluorescence microscopy using anti-IFB2 (left) and anti-ERM-1 antibodies (middle; merged images at right) in dissected wild-type and mutant intestine. Note the colocalization of IFB-2, IFC-2, F-actin, and ERM-1 in cytoplasmic invaginations (arrows). Scale bars: 10 μm.](3855fig7){#F7}

The intestinal filament organizer IFO-1 acts additively with SMA-5
------------------------------------------------------------------

Because the recently characterized intestinal filament organizer IFO-1 plays a crucial role in correct localization of the subapical intermediate filament and actin cytoskeleton in the intestine ([@B5]), we examined the distribution of IFO-1 in the *sma-5* mutant background. As expected, IFO-1 codistributed closely with IFB-2 in the subapical intestinal cytoplasm ([Figure 8, A--A″](#F8){ref-type="fig"}). It also codistributed in mature invaginations of *sma-5(RNAi)*-treated animals ([Figure 8, B--B″](#F8){ref-type="fig"}). Slight differences between IFO-1 and IFB-2 distribution were, however, occasionally detectable, especially in smaller invaginations, where strong IFO-1 fluorescence was detectable without significant IFB-2 ([Figure 8, B--B″](#F8){ref-type="fig"} and Supplemental Figure S5). The findings indicate either that IFO-1 precedes cytoplasmic translocation of IFB-2 or that cytoplasmic invaginations occur at positions of a discontinuous, that is incomplete, IFB-2 network.

![Intestine-specific *sma-5(RNAi)* animals and *sma-5* mutants develop IFB-2- and IFO-1--positive cytoplasmic invaginations. (A--C″) Antibody staining detecting IFB-2 and IFO-1 in the dissected adult intestine of intestine-specific RNAi strain OLB11 (A--A″), OLB11 treated with *sma-5(RNAi)* (B--B″), and *sma-5(n678)* mutants (C--C″). (D--F″) In vivo fluorescence detection of IFB-2::CFP and IFO-1::YFP (inverted presentation in D, D′; E, E′, F, F′; corresponding interference contrast images in D″, E″, F″, respectively) in wild-type strain BJ276 (WT; D--D″) and *sma-5(kc1)* animals of strain BJ277 (E--F″). The images depict the characteristic apical colocalization of IFB-2 and IFO-1 that is maintained in the cytoplasmic invaginations forming in the mutant backgrounds. Note that invaginations are usually marked by both (arrowheads), although occasionally IFO-1--positive invaginations lack IFB-2 (e.g., arrows in B--B″). Scale bars: 10 μm in A--C″; 20 μm in D--F″; 10 μm in insets of E--E′; 20 μm in insets of F--F′; 5 μm in insets of B--B″.](3855fig8){#F8}

To further investigate the genetic relationship between *sma-5* and *ifo-1*, we prepared double knockdowns. Supplemental Figure S6 shows that *ifo-1(RNAi)* in *sma-5(kc1)* induced both the *sma-5--*dependent cytoplasmic invaginations and the enrichment of IFB-2 at the CeAJ that is typically found in *ifo-1* mutants. Junctional integrity remained intact, and no additional phenotype was detected. The additive nature of the phenotype indicates that the mutations act on intermediate filament network organization at least in part through separate pathways.

SMA-5 is needed for structural maintenance of the intermediate filament--rich endotube and ordered arrangement of microvilli
----------------------------------------------------------------------------------------------------------------------------

Electron microscopy was performed to study luminal alterations at the ultrastructural level. In the wild-type situation (*n* = 3), the intestinal lumen, in transverse section, has a regular ellipsoid shape and is surrounded by evenly sized and regularly arranged microvilli of the brush border ([Figure 9, A--C](#F9){ref-type="fig"}; see also [@B5]; [www.wormatlas.org](http://www.wormatlas.org)). The intermediate filament--rich endotube appears as an electron-dense structure surrounding the lumen below the organelle-free terminal web (green arrowheads). It is anchored to the CeAJ at cell--cell borders (white arrowheads). When viewed in longitudinal section, *kc1* and *n678* mutants ([Figure 9, D--I](#F9){ref-type="fig"}; *n* = 4 for *kc1*; and *n* = 4 for *n678*) showed luminal pockets extending into the intestinal cytoplasm that were not observed in the wild type. The invaginations were still connected to the intestinal lumen, and no additional lumina were observed. These pockets are formed at transition zones where the endotube is considerably thinned (yellow arrowheads) or completely missing (red arrowheads). Overall local endotube thinning was observed in both mutant backgrounds, although it was more pronounced and combined with much larger gaps in *n678*. Local endotube thickening was not seen in *kc1* but was quite pronounced in *n678* (blue arrowheads). Taken together, these findings indicate that the continuity of the endotube is compromised in the mutant intestine, leading to cytoplasmic invaginations, and likely explains the reduced/absent decoration by IFB-2 ([Figure 8, B--B″](#F8){ref-type="fig"}, and Supplemental Figure S5). Furthermore, the regular microvillar arrangement was considerably perturbed in several regions (e.g., [Figure 9, I and L](#F9){ref-type="fig"}). Regular spacing and orthogonal protrusion of microvilli, which are so characteristic for a genuine brush border, were lost. Finally, the CeAJs were morphologically inconspicuous, supporting the observed functional integrity of the intestinal barrier ([Figure 9, J--L](#F9){ref-type="fig"}).

![Luminal perturbations, disordered microvilli, and endotube alterations with local gaps are present in the intestine of *sma-5* mutants. The electron micrographs are taken from wild type (transverse sections, A--C, J), *sma-5(kc1)* (longitudinal sections, D--F, K), and *sma-5(n678)* mutants (longitudinal sections, G--I, L). Differently sized luminal invaginations into the cytoplasm of enterocytes are seen in both mutants (D--H). Note that the endotube layer is indistinguishable from that of the wild type in some regions (green arrowheads) but is drastically altered in other regions. In *sma-5(kc1)* local endotube thinning (yellow arrowheads) and endotube gaps (red arrowheads) are observed. In *sma-5(n678)*, localized and extensive endotube thickening (blue arrowheads) and thinning (yellow arrowheads) with complete endotube loss (red arrowheads) are frequent. Note also that loss of endotube and endotube thinning coincide with the rim of cytoplasmic invaginations (E, F, and H). In addition, the brush border (B) is irregular in many regions, with variable spacing and orientation (e.g., I and L). The CeAJ appears unperturbed (white arrowheads in A--C, J--L) and is still associated with the material of the endotube. L, lumen; Y, yolk granule; F, lipid droplet. Scale bars: 2 μm in A, D, and G; 500 nm in B--C, E--F, and H--L.](3855fig9){#F9}

SMA-5 activity affects phosphorylation of intermediate filament proteins
------------------------------------------------------------------------

To test whether the observed structural alterations of the IF system are linked to altered phosphorylation of intermediate filament polypeptides, we performed two-dimensional gel electrophoresis and immunoblotting to detect changes in isoelectric points. [Figure 10](#F10){ref-type="fig"} shows results using anti--IFB-2 antibodies. In wild-type N2, a single isoelectric variant could be detected for the higher molecular weight isoform IFB-2a, while two isoelectric variants were visible for the lower molecular weight isoform IFB-2c with a major spot (2c and 2c^+1P^, respectively). Phosphatase treatment resulted in a shift of isoelectric points toward basic with the appearance of new immunoreactive signals labeled as 2a^−1P^ and 2c^−1P^. A different pattern of IFB-2 immunoreactivity was observed in lysates obtained from *sma-5(n678)* worms with an overall reduction of isoelectric points and appearance of new signals in the more acidic part of the pH gradient (2a^+1p^, 2a^+2P^, 2c^+2P^). Phosphatase treatment reversed this pattern toward more basic isoelectric variants. These data support the notion that intermediate filament polypeptides are phosphorylated and indicate that SMA-5 inactivation leads to increased intermediate filament phosphorylation. To examine whether this paradoxical effect might be mediated through altered ERM-1 phosphorylation, we performed immunoblots (Supplemental Figure S7). They show that the overall ERM-1 expression is reduced, while the fraction of phosphorylated ERM-1 remains unaltered in *n678* mutants.

![Two-dimensional immunoblot analysis of IFB-2 detects SMA-5--dependent phosphorylation. The picture shows immunoblots of polypeptides obtained from total worm lysates that were separated by two-dimensional isoelectric focusing gel electrophoresis (pH gradient of second dimension indicated on top) and reacted with monoclonal anti--IFB-2 antibodies. The higher magnifications at right depict details of the different IFB-2 isoforms that were detected. They differ in size (larger a and smaller c variant) and isoelectric points as a consequence of phosphorylation (+P, −P). Note that, at steady state, one a variant (denoted 2a) and two c variants, that is, a major spot denoted as 2c and a minor spot denoted as 2c^+1P^, are visible in the wild-type N2 background. As expected, phosphatase treatment leads to a shift to more basic isoelectric points (2a^−1P^ and 2c^−1P^). In contrast, isoelectric points are shifted toward acidic in the *sma-5(n678)* background, with new spots at 2a^+1p^, 2a^+2P^, and 2c^+2P^. Again, phosphatase treatment shifts the variants toward the nonphosphorylated positions. Indication of molecular weight in kilodaltons.](3855fig10){#F10}

DISCUSSION
==========

We provide genetic evidence that kinase activity is linked to intermediate filament network stability in the polarized simple epithelium of the *C. elegans* intestine by identifying the serine--threonine MAPK7 kinase orthologue SMA-5 as a key regulator of intermediate filament network organization. In *sma-5* mutants, the intermediate filament protein IFB-2 is hyperphosphorylated rather than hypophosphorylated, as one might expect if IFB-2 was a direct target of SMA-5. Therefore it is more likely that SMA-5 activates another kinase or inhibits a phosphatase that could then act on intermediate filaments. We describe phenotypic changes in the two mutant *sma-5* alleles, *n678* and *kc1*. The more severe phenotype in *n678* mutants is caused by a carboxy-terminal deletion of 75 amino acids, presumably yielding a nonfunctional polypeptide, while the much milder phenotype in *kc1* mutants is linked to a mutation in a single conserved residue within the catalytic domain that may render the encoded enzyme less active but not completely dysfunctional.

Our study extends previous work that first identified and characterized worms carrying the *n678* mutation ([@B73], [@B72]). However, these authors did not describe the drastic changes in cytoskeletal organization and luminal defects that we characterize here. Furthermore, our data are in contrast with the reported rescue of the *sma-5* phenotype by expression in the hypodermis. Instead, we show a complete rescue of the *sma-5* phenotype by intestine-specific reintroduction of a *sma-5* reporter. In accordance, we find a phenocopy of the *sma-5* phenotype, that is, reduced body length, growth retardation, reduced brood size, and shortened life span upon intestine-specific *sma-5(RNAi)*. We therefore conclude that the *sma-5* phenotype is caused by intestine-specific SMA-5 function.

In *sma-5* mutants, a morphologically normal subapical cytoskeleton forms around the lumen of the intestine initially but becomes progressively disorganized over time. We interpret the incremental appearance of the pathological phenotype as a consequence of kinase dysfunction resulting in impaired resilience of the endotube, which manifests as cytoplasmic invaginations upon prolonged and increasing wear and tear. However, the endotube in *sma-5* mutants appears to be fragile and eventually ruptures, perhaps because of stress from normal wear and tear or because of growth during development. The worm intestine seems to be sensitive to stress, and invaginations and luminal dilation occur in worms subjected to challenges such as microbial infection ([@B13]) or exposure to fungal lectins ([@B64]) or pore-forming toxins ([@B40]). In fact, the intestinal filament organizer IFO-1 is up-regulated in response to pore-forming toxins, and this up-regulation requires another MAP kinase, KGB-1 ([@B30]). In support of a protective role for the SMA-5 MAP kinase, the vertebrate homologue MAPK7 is activated by oxidative stress and hypo-osmolarity ([@B1]; [@B9]).

IFO-1 is a critical component of the organization of intermediate filaments in the intestine. During embryogenesis, IFO-1 accumulates at the apical plasma membrane before localization of intermediate filaments ([@B5]). Moreover, in *ifo-1* mutants, intermediate filaments collapse onto the CeAJ. In *sma-5* mutants, sites of IFO-1 delamination seem to precede the subsequent herniation of the intermediate filament protein IFB-2 and the lumen of the intestine. We stress, however, that the functions of IFO-1 and SMA-5 are separable, rather than being organized in a simple pathway. Loss of IFO-1 leads to intermediate filament accumulation at junctions, whereas loss of SMA-5 leads to a weakening of the intermediate filament--rich endotube leading to cytoplasmic invaginations. As expected, we find that *sma-5* and *ifo-1* phenotypes are additive in double knockdowns. Furthermore, loss of SMA-5 is coupled to intermediate filament hyperphosphorylation, whereas loss of IFO-1 does not lead to changes in intermediate filament phosphorylation (F.G., unpublished observations). Thus, even though IFO-1 is a potential target of kinases (phosphorylation site database, [www.phosida.com](http://www.phosida.com)), there must be additional SMA-5 targets whose phosphorylation affects intermediate filament phosphorylation and overall apical domain stability. A suppressor screen of the *sma-5* mutants could possibly identify the pathway that links SMA-5 to intermediate filament phosphorylation and network organization. It may also help to understand how and why SMA-5 dysfunction results in two opposing morphologies, namely endotube thinning and endotube thickening. It is possible that phosphorylation of different targets by SMA-5 may be important for network formation and network disassembly.

Our data suggest that the endotube itself becomes organized in a trilaminar structure, with an actin network closest to the plasma membrane anchoring the microvilli, followed by an IFB-2 intermediate filament layer and an IFO-1 layer below. First, we sometimes see that the IFO-1 layer has delaminated and buckled, whereas the IFB-2 layer is still intact. Second, we observe that the actin cytoskeleton is also disrupted in advanced endotube hernias. The observation that the displacement of actin, the actin-binding protein ERM-1, IFB-2, and IFC-2 occurs in concert and coincident with the formation of dextran-filled invaginations suggests that the intermediate filament network provides a major scaffolding on which the entire apical membrane domain rests. The existence of cross-bridges among the components in *C. elegans* is also supported by the observation of similar invaginations in *act-5(RNAi)*, *act-5(ok1397)*, *erm-1(RNAi)*, and *ifc-2(RNAi)* intestines ([@B20]; [@B26]; [@B55]). In accordance, ultrastructural and molecular links have been described among these components in mice ([@B23]; [@B19]).

Previous studies in cultured epithelial cells have indicated a role for kinase signaling in epithelial intermediate filament network organization. The ratio of filamentous to soluble keratin correlates with keratin phosphorylation in most, though not all, instances ([@B10]; [@B38]; [@B63]). Furthermore, inhibition of either tyrosine phosphatases or serine--threonine phosphatases resulted in rapid keratin network disruption ([@B62], [@B63]). Specifically, an involvement of the p38 MAP kinase has been demonstrated in phosphatase inhibitor--induced network disassembly into granular aggregates ([@B36]; [@B78]). In accordance, stimulation of p38 activity induced network disorganization, leading to the formation of large granules containing phosphorylated keratins ([@B78]). JNK and p38 MAP kinase--dependent keratin phosphorylation has been described for several stress paradigms such as osmotic imbalance and heat and chemical stress ([@B12]; [@B36]; [@B78]). It was further shown that cooperation between p38 MAP kinase and MAPKAP kinase MK2/3 is responsible for keratin phosphorylation in intestinal HT29-MTX cells ([@B47]). Remarkably, MK2-deficient mice become less sensitive to dextran sodium sulfate (DSS)-induced colitis ([@B39]). This situation is analogous to that encountered in our *sma-5* mutants. We suggest that the protective effect against stress is mediated in both instances by reduced intermediate filament phosphorylation resulting in a more resilient filament network. Furthermore, similar mechanisms may act in other cell systems. Thus it has been demonstrated that tension induces a mechanotransduction pathway in the *C. elegans* hypodermis, whose output is increased intermediate filament phosphorylation ([@B79]). It also involves a kinase (PAK-1) whose activity is stimulated by a hemidesmosomal mechanosensor acting through hemidesmosomal adaptor proteins and the Rac GTPase CED-10. It will be interesting to find out whether similar pathways involving SMA-5 exist in the *C. elegans* intestine.

The evolutionary conservation of the subapical distribution of intermediate filaments anchored to the apical junctional complex, either in the form of the prominent endotube in *C. elegans* or as a dense network below the terminal web in *Isotumurus maculatus* ([@B45]), to mouse ([@B23]) and man ([@B48]; [@B7]) can be taken as evidence for the functional importance of this arrangement. The small body size, reduced brood size, developmental retardation, and reduced life span observed in *sma-5* mutants (this study) and *ifo-1* mutants (unpublished data; [@B5]) all strongly support this notion. In addition, mechanical functions have been ascribed to intestinal intermediate filaments ([@B28]) and keratin mutations have been linked to intestinal inflammation in mice lacking keratins ([@B2]; [@B21]). Interestingly, keratin polymorphisms have been associated with intestinal bowel disease in human patients ([@B50]; [@B51]; [@B80]). In vitro observations provide further support for a function of intermediate filaments in intestinal barrier formation and its regulation by phosphorylation. Thus interleukin-6 (IL-6) activity evoked increasing phosphorylation of keratins 8 and 18 coincident with subapical intermediate filament accumulation in cultured colon carcinoma--derived Caco2-BBE cells ([@B71]). In accordance, IL-6 knockout mice presented with reduced keratin 8 levels and showed increased intestinal permeability after administration of dextran sulfate sodium (DSS) ([@B71]). The relationship between intestinal barrier function and keratin phosphorylation is also suggested by the work of [@B66], who demonstrated that hypo-osmosis induced site-specific dephosphorylation of keratin 8 in HT29 cells, whereas hyper-osmosis induced keratin 8 hyperphosphorylation. These observations are in contrast to reports in the same study noting keratin hyperphosphorylation in human HRT18 and Caco2 cells and in ex vivo colon cultures upon hypo-osmosis. But they also underscore the importance, though presently poorly understood relevance, of intermediate filament phosphorylation in different stress paradigms.

Taking these findings together, we conclude that intermediate filaments are crucial ingredients for the maintenance of the *C. elegans* intestinal tube, which is an important prerequisite for efficient food uptake. It is likely that they fulfill similar functions in other lumen-containing epithelial structures such as the excretory cells in *C. elegans* ([@B35]).

MATERIALS AND METHODS
=====================

DNA constructs
--------------

Fosmid WRM0633B_G09(pRedFlp-Hgr)(sma-5\[26688\]::S0001_pR6K_Amp_2xTY1ce_EGFP_FRT_rpsl_neo_FRT_3xFlag)dFRT::unc-119-Nat (here referred to as fosmid 3170) was obtained from the TransgeneOme Project of the Max Planck Institute of Molecular Cell Biology and Genetics ([@B56]; Transgene­Ome Project, <https://transgeneome.mpi-cbg.de/transgeneomics/index.html>). pWD553 was made by first cloning the *sma-5* cDNA into the *Pst*I*-Xma*I sites of plasmid *pPifb-2:cfp* (1759; [@B26]). Next the *ifb-2* promoter was replaced by the *vha-6* promoter. This was done with a Gibson reaction ([@B83]) of two fragments. The first fragment was a *Pst*I*-Hin*dIII digest. The second was a PCR of the *vha-6* promoter using primers TAACAACTTGGAAATGAAATAAGCTTaagtatactatttattactcgatacttttgttca and TGTGGAGGAGACATCTGCAGtttttatggg­ttttggtaggttttagtcgccctg. The PCR template was pML25 \[*vha-6p*\]. pWD554 was made by replacing the *cfp* coding sequence and the *unc-54* 3′-untranslated region (UTR) of pWD553 with the *let-858* 3′ UTR. This was done with a Gibson reaction ([@B83]) of two fragments. The first was a *Sma*I*-Spe*I digest of pWD553. The second was a PCR of the *let-858* UTR using the primers ATTGCGCAGCAACCCGGGTAAcTCGACGCCaACGTCGTTGAattttc and GGCCCGTACGGCCGAAACCAAGCGAGGACAATTCTcatcg and pADA126 ([@B74]) as a template. pWD555 was made by adding three native introns into the *sma-5* cDNA. This was done using a Gibson reaction ([@B83]) of two fragments. The first was a *Bam*HI*-Bgl*II digest of pWD554, and the second was a PCR from worm genomic DNA using primers tcttcatcatatcatttatggaaacgaggatccattggaggaaca and catgctgatcaattcttgatgattgagatcttcaacttgcatc. The *sma-5(RNAi)* feeding vector was produced by cloning the coding sequence of W06B3.2a exon 5 into the *Xba*I/*Bam*HI restriction sites of vector L4440 (Addgene, Cambridge, MA) using forward primer ACGGATCCTATCTTCATGCTGCATGCATCGCT and reverse primer ACTCTAGAATCATCTCCTCGAGCTTTGCAGAA.

*C. elegans* strains
--------------------

Wild-type Bristol strain N2 and Hawaiian strain CB4856 were obtained from the *Caenorhabditis* Genetics Center (CGC; University of Minnesota, Minneapolis, MN). Strain BJ52 *kcIs21\[ifb-2p::ifb2::cfp\]V* was recently described ([@B26]; for chromosomal mapping, see [@B25]). *sma-5* mutant strains carrying allele *kc1* were BJ132 *sma-5(kc1)X;kcIs21\[ifb-2p::ifb-2::cfp\]V* and BJ141 *sma-5(kc1)X*. Strain FK312 *sma-5(n678)X* ([@B72]) was provided by the CGC. It was crossed with BJ49 *kcIs6\[ifb-2p::ifb-2::cfp\]IV* ([@B26]; for chromosomal mapping, see [@B25]) to obtain strain OLB18 *sma-5(n678)X;kcIs6\[ifb2-p::ifb-2::cfp\]IV*. BJ276 *kcIs30*\[*ifo-1p::ifo-1::yfp;myo-3p::mCherry::unc-54*\]*;kcIs21\[ifb-2p::ifb2::cfp\]V* and BJ277 *sma-5(kc1)X;kcIs30*\[*ifo-1p::ifo-1::yfp,myo-3p::mCherry::unc-54*\]*;kcIs21\[ifb-2p::ifb2::cfp\]V* were both generated in one step by crossing BJ132 with BJ186 *kcIs30\[ifo-1p::ifo-1::yfp;myo-3p::mCherry::unc-54\]III* animals. Microinjection of fosmid 3170 into the gonad of DP38 *unc-119(ed3)* animals (provided by the CGC) resulted in strain BJ263 *kcEx73\[pRedFlp-Hgr)(sma-5\[26688\]:: S0001_pR6K_Amp_2xTY1ce_EGFP_FRT_rpsl_neo_FRT_3xFlag)dFRT::unc-119-Nat\]* producing SMA-5::EGFP. Rescue strain BJ269 *sma-5(kc1)X;kcEx73\[pRedFlp-Hgr)(sma-5\[26688\]::S0001_pR6K_Amp\_ 2xTY1ce_EGFP_FRT_rpsl_neo_FRT\_ 3xFlag)dFRT::unc-119-Nat\]* was generated by microinjection of fosmid 3170 into BJ141 *sma-5(kc1)X* animals. Rescue strains BJ300/301 *sma-5(n678)X; kcEx75\[vha-6p::sma-5;myo-2p::gfp::H2B*\] were generated by microinjection of plasmid pWD555 and pCFJ770 \[*myo-2p::gfp::H2B\]* into OLB18 animals. Microinjection of plasmid 1772 \[*ifb-2p::ifb-2::cfp*\] ([@B26]) into the gonad of strain EC668 *kcEx41\[unc-119(+);ifa-1a::gfp\];unc-119(ed3)III* ([@B32]) yielded strain BJ37 *kcEx4\[ifb-2p::ifb-2::cfp\]; kcEx41\[unc-119(+);ifa-1a::gfp\];unc-119(ed3)III*. Strain OLB11 *rde-1(ne219)*; *kcIs39*\[pOLB11 (*elt-2p::rde-1(+))*; pRF4*(rol-6(su1006))*\], which allows intestine-specific RNAi, was previously described ([@B53]). Maintenance and propagation of strains was done as previously described ([@B4]).

RNAi
----

RNAi by feeding was performed as previously described ([@B26]) with minor modifications. Nematode growth medium (NGM) plates contained 100 μg/ml ampicillin, 12.5 μg/ml tetracycline, and 2 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG). Plasmid clones for RNAi were either taken from the Ahringer RNAi library (Geneservice, Cambridge, UK) or obtained by cloning gene sequences of at least 500 base pairs containing a minimum of one coding exon into the feeding vector L4440 (Addgene) followed by chemical transformation into RNaseIII-deficient HT115 *Escherichia coli*. Liquid overnight cultures in Luria broth with 100 μg/ml ampicillin and 12.5 μg/ml tetracycline were supplemented with 7 μl/ml 1 M IPTG before plates were inoculated with a volume of 300 μl each. After overnight incubation at room temperature, 10--20 L4 larvae were added; this was followed by incubation at 15°C or 18°C. After 48 h, adult grown animals were transferred to new plates and incubated as before until F~1~ progeny could be analyzed. Alternatively, RNAi by microinjection was performed. To this end, dsRNA was first amplified in vitro using the MAXIscript T7 Kit (Ambion, Austin, TX) and then injected into L4 larvae using the inverse Leica DM IRB microscope (Leica, Wetzlar, Germany). Injected animals were subsequently incubated for 24 h at 20°C on normal NGM plates and transferred onto new plates for examination of F~1~ progeny.

Isolation and identification of *sma-5* mutants
-----------------------------------------------

BJ52 *kcIs21\[ifb-2p::ifb2::cfp\]V* animals were subjected to chemical mutagenesis by incubating adult worms with 47 mM ethyl methane sulfonate for 4 h at room temperature. F~2~ progeny corresponding to 10,000 haploid genomes were screened for alterations of IFB-2::CFP fluorescence. Isolated animals were backcrossed five times with N2 to obtain strain BJ132 *sma-5(kc1)X;kcIs21\[ifb-2p::ifb-2::cfp\]V*. Further identification of the mutated gene was done by single-nucleotide polymorphism mapping ([@B11]; [@B5]) and RNAi targeting of the remaining 94 candidate genes within the mapped region. An RNAi screen was performed by bacterial feeding (Ahringer library) starting either with L1 or L4 larva of strain BJ52 at 18°C or 20°C, resulting in down-regulation of postembryonic or embryonic gene function, respectively. In some instances, RNAi by microinjection of dsRNA was also performed, when appropriate feeding clones were not available. Animals were screened for a copy of the *sma-5(kc1)* phenotype using a fluorescence binocular.

Immunostaining and fluorescence labeling
----------------------------------------

For immunohistology, animals were dissected in phosphate-buffered saline on a poly-[l]{.smallcaps}-lysine--coated glass slide; this was followed by mounting a coverslip on top, removing excessive fluid, and freezing the sample in liquid nitrogen. The coverslip was then blasted off, resulting in permeabilization of the cuticle. Samples were then fixed by incubation at −20°C first for 10 min in methanol and then for 20 min in acetone, followed by incubation in a graded ethanol series (5 min in 90% ethanol at −20°C, 5 min in 60% ethanol at −20°C, and 5 min in 30% ethanol at room temperature). After a 10 min washing in TBST (TBS buffer \[20 mM (wt/vol) Tris(hydroxymethyl)-aminomethane, pH 7.6, 0.15 M (wt/vol) NaCl\] + 0.2% Tween 20), samples were incubated with primary antibodies dissolved in blocking solution (1% \[wt/vol\] nonfat milk powder \[Roth, Karlsruhe, Germany\], 1% \[wt/vol\] bovine serum albumin, and 0.02% \[wt/vol\] sodium azide) overnight at 4°C. Following a 10 min wash in TBST, samples were incubated with secondary antibodies dissolved in blocking solution for 2 h at room temperature. After a final wash for 10 min in TBST, samples were embedded in Mowiol 4--88 (Sigma, St. Louis, MO) supplemented with DABCO (Roth) and covered with a glass coverslip. The following primary antibodies were used: guinea pig anti--IFO-1 (1:100; [@B5]), guinea pig anti--IFC-2 (1:10; [@B31]), rabbit anti-DLG-1 (1:200; [@B58]), rabbit anti--ERM-1 (1:200; [@B70]), mouse monoclonal anti--IFB-2 (MH33, 1:200; [@B17]), rabbit anti--GFP (1:1000; Invitrogen, Carlsbad, CA), and mouse monoclonal anti--AJM-1 (MH27, 1:200; [@B17]). Secondary antibodies used at 1:200 dilution were Cy2-, Cy3-conjugated affinity-purified anti-mouse immunoglobulin G (IgG; Rockland, Limerick, PA), Alexa Fluor 488--conjugated affinity-purified anti-mouse IgG (Invitrogen), Alexa Fluor 555--conjugated affinity-purified anti-mouse IgG (Invitrogen), Dylight488- and Cy3-conjugated affinity-purified anti--guinea pig IgG, Cy2-, Cy3-, Cy5-conjugated anti-rabbit IgG (Jackson ImmunoResearch Laboratories, West Grove, PA), and Alexa Fluor 488--conjugated affinity-purified anti-rabbit IgG (Invitrogen). Actin filaments were stained by Alexa Fluor 546--phalloidin (Molecular Probes, Eugene, OR).

To label the intestinal lumen and to check for intestinal tightness, young adults were incubated on agar plates containing 100 μl of 0.3% (wt/vol) Texas Red--conjugated dextran (10,000 MW; Molecular Probes) in the presence of OP50 bacteria at room temperature for 24 h. They were subsequently washed three times in M9 medium before being imaged.

Microscopy
----------

Microscopy was performed with confocal laser-scanning microscopes (LSM 510 META and LSM 710, Zeiss; Jena, Germany; TCS SP5; Leica), a Zeiss Apotome fitted with a Zeiss AxioCamMRm camera, and a Zeiss Axioplan 2 fitted with an ORCA-ER camera (Hamamatsu, Herrsching, Germany). For electron microscopy, worms were cryofixed by rapid high-pressure freezing with the help of a Leica EM Pact high-pressure freezer. For each genotype, at least 10 samples, each consisting of 5--15 worms, were fixed. Quick-freeze substitution was done using two alternative fixatives: 1) 1% OsO~4~, 0.2% uranyl acetate in acetone; and 2) 1% OsO~4~, 0.5% uranyl acetate, and 5% H~2~O in acetone. Embedding into epoxy resin was performed as previously described ([@B44]). Following quick-freeze substitution, 50 nm transverse and longitudinal ultrathin sections of the worms were prepared with a Leica UC6/FC6 ultramicrotome, contrasted for 10 min each in 1% uranyl acetate in ethanol followed by Reynolds lead citrate. Sections were viewed at 100 kV with a Hitachi H-7600 transmission electron microscope (Tokyo, Japan).

Immunoblotting
--------------

For each assay, 60 adult worms of the wild type or 120 *sma-5(n678)* mutant animals were handpicked, transferred into 30 μl dH~2~O, and immediately frozen at −80°C. After quick thawing, samples were sucked up and down through a 30G hypodermic syringe (BD Medical, Heidelberg, Germany) three times. Subsequently, 7.5 μl of 5× Laemmli loading buffer was added, and samples were incubated for 5 min at 90°C. Proteins were separated in a 10% SDS polyacrylamide gel, and transferred onto polyvinylidene difluoride membrane by wet-tank blotting at 100 V for 60 min. The membranes were blocked for 1--2 h at room temperature in Roti-Block (Roth) and then incubated with primary antibodies in Roti-Block at 4°C overnight. Antibodies against total ERM-1 (murine monoclonal antibodies from the Developmental Studies Hybridoma Bank \[DHSB, Iowa City, IA\]; [@B22]) were diluted 1:1000, against phosphorylated ERM-1 (rabbit monoclonal antibodies ab76247 from Abcam, Cambridge, UK) 1:500, and against actin (rabbit polyclonal antibodies A2066 from Sigma) 1:1000. Three 10 min washings with TBST (20 mM Tris(hydroxymethyl)-aminomethane, 0.15 M NaCl, 0.1% Tween 20 \[vol/vol\], pH 7.6) ensued. Incubation with secondary antibodies (goat anti-mouse IgG antibodies and goat anti-rabbit IgG antibodies coupled to horseradish peroxidase from DAKO \[Santa Clara, CA\] at 1:5000 in Roti-Block) was done for 1 h at room temperature. Final washes (three at 10 min each) were in TBST. Bound antibodies were detected with Fusion Solo (Vilber, Eberhardzell, Germany) using chemiluminescence substrate AceGlow (Peqlab, Darmstadt, Germany).

For two-dimensional gel electrophoresis, 60 adult worms were handpicked for each assay, transferred into 15 μl dH~2~O, and immediately frozen at −80°C. After quick thawing, each sample was aspirated by a syringe needle three times, resulting in homogenization, and stored on ice for at least 30 min after addition of 15 μl 2× lysis buffer (9.5 M urea, 4% \[wt/wt\] 3-\[(3-cholamidopropyl)dimethylammonio\]-1-propanesulfonate, 0.04% \[wt/vol\] bromophenol blue, 2% \[wt/vol\] dithiothreitol \[DTT\], 2% \[vol/vol\] Immobilized pH Gradients buffer \[GE Healthcare, Freiburg, Germany\]). Then 170 μl 2× lysis buffer was added, and all of the solution (200 μl) was transferred to an Immobiline DryStrip (pH 4-7, 11 cm; GE Healthcare) for overnight rehydration. During this time, the strip was covered by silicone oil to prevent sulfuring of urea. For isoelectric focusing, the following protocol was used: 150 V, 75 V/h; 300 V, 225 V/h; 1000 V, 500 V/h; and 3000 V, 27,000 V/h. Strips were sometimes stored at −80°C until further usage. For subsequent immunoblot analysis, strips were first washed for 15 min in 0.1 g DTT/10 ml equilibration buffer (6 M urea, 2% \[wt/vol\] SDS, 50 mM \[wt/vol\] Tris(hydroxymethyl)-aminomethane, pH 8.8, 0.02% \[wt/vol\] bromophenol blue, 30% \[vol/vol\] glycerol); this was followed by another washing step for 15 min in 0.25 g iodoacetamide/10 ml equilibration buffer. Strips were then placed on top of the solidified stacking gel and further embedded by agarose (0.5% \[wt/vol\] agarose, 0.02% \[wt/vol\] bromophenol blue in running buffer \[0.25 M Tris(hydroxymethyl)-aminomethane, 1.92 M \[wt/vol\] glycine, 1% \[wt/vol\] SDS\]). After gel electrophoretic separation, proteins were transferred onto polyvinylidene difluoride membrane by tank blotting at 100 V for 70 min. After blocking for 1--2 h at room temperature in Roti-Block (Roth), immunostaining against IFB-2 was done by incubating the blots with primary antibody MH33 (1:1000 dilution in Roti-Block) at 4°C overnight, washing 3 × 10 min in TBST, incubating with secondary mouse anti-mouse IgG antibodies coupled to horseradish peroxidase from DAKO at 1:5000 in Roti-Block, diluting for 1 h at room temperature, and administering final washes in TBST. Bound antibodies were detected with Fusion Solo using chemiluminescence substrate AceGlow.
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